IP Verse

Brand Murray Fuller competitive analysis

Explore patent oppositions filed by Brand Murray Fuller against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026

Patent Number	Title	Applicant	Opposition Date
EP4188389	Methods Of Treating Chronic Kidney Disease With Dapagliflozin	ASTRAZENECA	Jun 16, 2026
EP4385509	Migalastat Formulations Having Improved Pharmacokinetics	AMICUS THERAPEUTICS	Jun 3, 2026
EP4374918	Methods Of Treating Fabry Patients Having Renal Impairment	AMICUS THERAPEUTICS	Apr 15, 2026
EP4403228	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Apr 8, 2026
EP4188327	Combination Therapy For Inhalation Administration	CHEMO RESEARCH	Feb 26, 2026
EP3756650	Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione	AMGEN EUROPE	Jan 12, 2026
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Jan 2, 2026
EP3329965	Dosing Regimen Of Anti-Alpha4Beta7-Antibodies	MILLENNIUM PHARMACEUTICALS	Dec 17, 2025
EP4234033	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Oct 23, 2025
EP3321270	Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-Olate	GILEAD SCIENCES	Sep 4, 2025

Discover the latest PTAB cases involving Brand Murray Fuller, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Brand Murray Fuller with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BRAND MURRAY FULLER	32	-	-	-
AMICUS THERAPEUTICS	-	24	-	-
F HOFFMANN LA ROCHE	16	195	-	-
NOVARTIS	6	472	-	21